4th Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for FERRING PHARMACEUTICALS INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

issues related to microbiome, oncology, fertility, and health equity Issues related to formulary tier status NDAA FY24

Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in health equity.

LobbyistCovered position, as disclosed
WILLIAM DUNHAM —
EMILY FELDER —
ZACHARY PFISTER —
ADAM STEINMETZ —
GREGORY SUNSTRUM —
DEEMA TARAZI New —
JONATHAN TOWERS —
ANDREW USYK —
ARI ZIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.